ILIB (intravascular laser irradiation of blood) as an adjuvant therapy in the treatment of patients with chronic systemic diseases-an integrative literature review
| Autor: | Gabriella de Vasconcelos Neves, Ruan Felipe Ferreira Tomé, Ana Karina Almeida Rolim, Daliana Queiroga de Castro Gomes, Carlus Alberto Oliveira dos Santos, Diego Filipe Bezerra Silva |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty Dermatology 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Integrative literature review Adjuvant therapy medicine Humans Low-Level Light Therapy Intensive care medicine Child Aged Access route business.industry Therapeutic effect Type 2 Diabetes Mellitus 030206 dentistry Middle Aged Clinical trial Diabetes Mellitus Type 2 Inclusion and exclusion criteria Chronic Disease Surgery Female Medline database business |
| Zdroj: | Lasers in medical science. 35(9) |
| ISSN: | 1435-604X |
| Popis: | To perform an integrative review of the literature on the effectiveness of intravascular laser irradiation of blood (ILIB) as an adjunct therapy in the treatment of chronic systemic diseases. This is an integrative literature review that included non-randomized and randomized controlled clinical trials that specifically evaluated the therapeutic effect of ILIB on chronic systemic diseases, without restriction of time, and written in English. The Medical Publications (PubMed)/MEDLINE database was used. MeSH (Medical Subject Headings) was used to select search descriptors with the Boolean operators "AND/OR." After applying the inclusion and exclusion criteria, 13 articles were selected. Coronary diseases were the most prevalent, followed by type 2 diabetes mellitus, with the coronary artery being the most widely used access route for ILIB application. Despite the varied parameters and protocols for using this kind of therapy, all studies have shown satisfactory results in the patients' clinical condition. ILIB proved to be effective in all organic systems, showing some positive result. However, studies on the effect of this therapy on various diseases are still scarce in the literature, and there is a need for more well-designed clinical trials to better understand the role of ILIB in various systemic diseases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink